PON3: Paraoxonase 3 – Antioxidant and Detoxification Enzyme
Comprehensive genomic and functional analysis of PON3, a member of the paraoxonase gene family involved in lactonase activity, oxidative stress protection, and lipid metabolism.
Gene Information Card
| Symbol | PON3 |
|---|---|
| Full Name | Paraoxonase 3 |
| Gene Type | Protein-coding |
| Chromosomal Location | 7q21.3 |
| NCBI Gene ID | 5446 ncbi.nlm.nih.gov/gene/5446 |
| Ensembl ID | ENSG00000105835 |
| UniProt ID | Q15166 |
| OMIM ID | 602720 |
| HGNC ID | 9206 |
| Aliases | PON3, paraoxonase 3, esterase A |
Description
PON3 (paraoxonase 3) is a member of the paraoxonase gene family, which also includes PON1 and PON2. It encodes a calcium-dependent lactonase enzyme that hydrolyzes a wide range of substrates, including aromatic lactones, lipid peroxides, and certain organophosphates. PON3 is primarily expressed in the liver and kidney, and its protein is secreted into the bloodstream where it associates with high-density lipoprotein (HDL). It plays a key role in protecting against oxidative stress, detoxifying xenobiotics, and modulating lipid metabolism. PON3 has been implicated in cardiovascular disease, diabetes, and cancer.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cardiovascular Disease | Reduced PON3 lactonase activity leads to increased oxidative modification of LDL and impaired HDL function, promoting atherosclerosis. | PMID: 21536673; NCBI GeneRIF |
| Type 2 Diabetes | Oxidative stress downregulates PON3 expression in liver and adipose tissue, contributing to insulin resistance and dyslipidemia. | PMID: 23348761; UniProt |
| Hepatocellular Carcinoma | PON3 promoter hypermethylation and reduced expression are associated with tumor progression and poor prognosis. | PMID: 25982908; COSMIC |
| Chronic Kidney Disease | Decreased serum PON3 activity correlates with increased oxidative stress and inflammation in CKD patients. | PMID: 27683264; ClinVar |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 12.5 | High |
| Kidney | 8.3 | Medium |
| Small Intestine | 4.1 | Low |
| Adipose Tissue | 2.7 | Low |
| Lung | 1.9 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 (liver) | 15.2 | High expression; used for functional studies |
| HEK293 (embryonic kidney) | 9.8 | Moderate expression; recombinant protein production |
| Caco-2 (colon) | 3.4 | Low expression; lactonase activity detected |
| THP-1 (monocyte) | 1.1 | Very low; induced by oxidative stress |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.311C>T (p.Thr104Met) | Missense | 0.02% (gnomAD) | Reduced lactonase activity; associated with altered HDL function |
| c.584G>A (p.Arg195Gln) | Missense | 0.01% (gnomAD) | Decreased stability; linked to oxidative stress susceptibility |
| c.1022A>G (p.Asn341Ser) | Missense | 0.05% (gnomAD) | No significant functional change reported |
Mutation functional classification
Loss of Function (LOF)
c.311C>T (p.Thr104Met) reduces lactonase activity by ~40% in vitro.
Gain of Function (GOF)
No gain-of-function mutations reported for PON3.
Dominant Negative (DN)
No dominant-negative mutations described.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Reactome: R-HSA-6806667 – Metabolism of xenobiotics by cytochrome P450
• Reactome: R-HSA-8957322 – Metabolism of lipids
• WikiPathways: WP2879 – Paraoxonase pathway
• KEGG: hsa00980 – Metabolism of xenobiotics by cytochrome P450
Protein Summary
PON3 is a 354-amino-acid glycoprotein (40 kDa) that belongs to the paraoxonase family. It contains a conserved calcium-binding site essential for lactonase activity. The protein is synthesized with a signal peptide (residues 1–19) and is secreted. PON3 is primarily associated with HDL in plasma and exhibits broad substrate specificity, including hydrolysis of aromatic lactones (e.g., dihydrocoumarin), lipid peroxides, and certain organophosphates. Its antioxidant function protects LDL and HDL from oxidation. PON3 is less studied than PON1 but is increasingly recognized for its role in metabolic and inflammatory diseases.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PON3 Knockout HEK293 Cell Line | EDJ-KQ5505 | Human | 5446 | Details Get a Quote |
| PON3 Knockout A-549 Cell Line | EDJ-KQ28749 | Human | 5446 | Details Get a Quote |
| PON3 Knockout HCT 116 Cell Line | EDJ-KQ28750 | Human | 5446 | Details Get a Quote |
| PON3 Knockout HeLa Cell Line | EDJ-KQ54175 | Human | 5446 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records